Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
Condition: Acute Ischemic Stroke Intervention: Biological: UMC119-06 Sponsor: Meridigen Biotech Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials